한빛사
>
한빛사논문
한빛사논문
- 조회2,078
Adv. Drug Deliv. Rev., Available online 17 March 2016 | doi:10.1016/j.addr.2016.03.002
Bioengineered protein-based nanocage for drug delivery
Abstract
Eun Jung Leea, Na Kyeong Leea, b, In-San Kima, c,*
a Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, 5, Hwarang-ro 14-gil, Seongbuk-gu, Seoul 02792, Republic of Korea
b Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea
c KU-KIST School, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Republic of Korea
*Corresponding author.
Abstract
Nature in its wonders presents and assembles the most intricate and delicate protein structures and this remarkable phenomenon occurs in all kingdom and phyla of life. Of these proteins, cage-like multimeric proteins provide spatial control to biological processes and also compartmentalizes compounds that may be toxic or unstable and avoids their contact with the environment. Protein-based nanocages are of particular interest because of their potential applicability as drug delivery carriers and their perfect and complex symmetry and ideal physical properties that stimulates researchers to engineer, modify or mimic these qualities. This article reviews various existing types of protein-based nanocages that are used for therapeutic purposes, and outlines their drug-loading mechanisms and bioengineering strategies via genetic and chemical functionalization. Through a critical evaluation of recent advances in protein nanocage-based drug delivery in vitro and in vivo, an outlook for de novo and in silico nanocage designing, and also protein-based nanocage preclinical and future clinical applications will be presented.
논문정보
- Review Paper
- 2016년 03월 (BRIC 등록일 2016-03-23)
- 국내 연구진
- 바이오·의료융합 > 바이오센싱 및 나노바이오물질
댓글 작성 로그인
팝업 닫기관련 링크
관련분야 연구자보기
관련분야 논문보기
해당논문 저자보기
